Navigation Links
NeurogesX to Report Second Quarter 2008 Financial Results
Date:8/5/2008

SAN MATEO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will report results for its second quarter 2008 on Wednesday, August 13, 2008, after the market closes.

A conference call to review the results will begin at 4:30 p.m. ET (1:30 p.m. PT) on August 13, 2008 and will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer.

To participate in the conference call, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). In addition, a dial-up replay of the conference call will be available beginning August 13, 2008 at 8:00 p.m. ET (5:00 p.m. PT) and ending on August 23, 2008. The replay telephone number is 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 292266.

A live web cast of the call will also be available from the Investor Relations section on the corporate web site at http://www.neurogesx.com. A web cast replay can be accessed on the corporate web site beginning August 13, 2008 at the same time as the conference call and will remain on the site for one month ending September 13, 2008.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... GA (PRWEB) May 06, 2015 ... based on the products of cells grown under ... its 105F immunomodulatory treatment candidate for melanoma during ... Meeting, taking place May 6-9, 2015 in Atlanta, ... multipotent cells produce a soluble material with anti-oncologic ...
(Date:5/6/2015)... The Remedy Group , the ... the specialty pharmacy industry, will be exhibiting, presenting, and ... Pharmacy Summit. The Summit will be held May 4-8, ... is the largest annual gathering for the specialty pharmacy ... pharmacy providers, pharma/biotech manufacturers, and payers, to learn more ...
(Date:5/5/2015)... 5, 2015  Blueprint Medicines (NASDAQ: BPMC ... public offering of 9,367,708 shares of common stock ... share, including shares of common stock issued upon ... option to purchase additional shares. The gross proceeds ... were approximately $168.6 million, before underwriting discounts and estimated ...
(Date:5/5/2015)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... detection of foodborne pathogens,  today announced that Paul G. ... Lynch 2015 Health Care Conference on May 12 at 8:00am ... Wynn, Las Vegas NV. ... through the investor relations section of Roka Bioscience,s website at ...
Breaking Biology Technology:Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2The Remedy Group presenting at the 2015 Armada Specialty Pharmacy Summit: The Pitfalls to Growth and Maintaining the Patient Experience 2Blueprint Medicines Announces Closing of Initial Public Offering 2
... Two more Kansas,State University faculty have been ... society., Subbaratnam Muthukrishnan, university distinguished professor ... of,plant pathology, have been named Fellows of ... for their scientifically or socially,distinguished efforts to ...
... Biomedtex Inc.,(Pink Sheets: BMDX.PK) ("Biomed" or "the Company") ... initial direction for,its first line of health-conscious products ... will consist of several high-end specialty,lines of flavored ... being the first, while maintaining a price point,consistent ...
... 25 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... at 8:00 a.m. ET on Thursday, November 1, ... financial and,operational results and upcoming activities. A presentation ... the webcast. Prior to the,conference call on Thursday, ...
Cached Biology Technology:K-State's Subbaratnam Muthukrishnan and Barbara Valent Named Fellows of the American Association for the Advancement of Science 2Biomedtex Inc. Announces Direction of Initial Product Line 2Millennium to Webcast Third-Quarter 2007 Financial and Operational Results 2
(Date:4/9/2015)... 9, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the third ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... The National Institute of Standards and Technology (NIST) has ... ginkgo biloba, one of the most popular dietary supplements ... $1 billion. The NIST reference materials are ... methods for flavonoids and terpene lactones (plant constituents that ...
... PKMzeta maintains long-term memories in the neocortex and ... memory to endure, according to a finding by researchers ... Downstate Medical Center in Brooklyn, New York. The study ... magazine ( www.sciencemag.org ). The title of the paper ...
... dioxide often means danger - too many animals breathing ... exhaling nearby. Mice have a way of detecting carbon ... a special set of olfactory neurons is involved, a ... in atmospheric carbon dioxide may affect animal behavior. The ...
Cached Biology News:Ginkgo SRMs: Tools for product analysis/quality 2Mice use specialized neurons to detect carbon dioxide in the air 2